On July 6, 2023, the Food and Drug Administration granted full approval to Biogen (NASDAQ:BIIB) and Eisai’s (OTCPK:ESALF, OTCPK:ESAIY) anti-amyloid antibody drug Leqembi. For...
Private-equity firm TPG Inc. TPG, +2.84% will acquire the government-cybersecurity unit of software company Forcepoint for about $2.45 billion, the Wall Street Journal reported...
Written by Nick Ackerman, co-produced by Stanford Chemist. This article was originally published to members of the CEF/ETF Income Laboratory on June 25th, 2023....